Skip to main content

Clinical Diagnosis and Atypical Forms of NF1

  • Chapter
  • First Online:
Neurofibromatosis Type 1

Abstract

Neurofibromatosis type 1 (NF1) (MIM 162200) is inherited as an autosomal dominant trait and affects all ethnic groups. In this chapter, we review the NIH clinical diagnostic criteria with particular emphasis on NF1 in different age groups. We also discuss atypical forms of NF1. Diagnosing young children without an NF1 family history is challenging since sporadic cases often present with only one of the NF1 signs during the first years and hence do not fulfill the NIH diagnostic criteria. Mutation analysis of the NF1 gene may thus be particularly useful in the youngest age group in confirming the diagnosis. In children over 5–6 years and in adults, NF1 can be diagnosed in over 90 % of cases using the NIH criteria. Café-au-lait macules are one of the key diagnostic signs of NF1 since they manifest at an early age and are the most invariable signs of NF1. However, the differential diagnosis of café-au-lait macules is not always simple since other lesions may mimic these pigment spots, and café-au-lait macules are found in numerous other syndromes apart from NF1. Solitary café-au-lait macules, common “birth marks,” occur also in 10–15 % of the general population.Two or more neurofibromas are a diagnostic sign of NF1, but it is worth noting that single neurofibromas are not uncommon in healthy individuals. If the diagnosis of NF1 is not certain, removing one or two cutaneous neurofibromas for histology is indicated. The differential diagnosis of neurofibromas includes common melanocytic nevi, lipomas, and schwannomas. This chapter addresses the differential diagnosis of selected syndromes with multiple tumors and those with pigment lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alivuotila L, Hakokari J, Visnapuu V, Korpijaakko-Huuhka AM, Aaltonen O, Happonen RP, Peltonen S, Peltonen J (2010) Speech characteristics in neurofibromatosis type 1. Am J Med Genet A 152A:42–51.

    Article  PubMed  Google Scholar 

  • Almeida MQ, Stratakis CA (2010) Solid tumors associated with multiple endocrine neoplasias. Cancer Genet Cytogenet 203:30–36.

    Article  PubMed  Google Scholar 

  • Blumenthal GM, Dennis PA (2008) PTEN hamartoma tumor syndromes. Eur J Hum Genet 16:1289–1300.

    Article  PubMed  CAS  Google Scholar 

  • Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39:1120–1126.

    Article  PubMed  CAS  Google Scholar 

  • De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288–1292

    Article  PubMed  Google Scholar 

  • DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105:608–614

    Article  PubMed  CAS  Google Scholar 

  • Descheemaeker MJ, Roelandts K, De Raedt T, Brems H, Fryns JP, Legius E (2004) Intelligence in individuals with a neurofibromatosis type 1 microdeletion. Am J Med Genet A 131:325–326.

    Article  PubMed  CAS  Google Scholar 

  • Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B (2002) Grouping of multiple lentigines/LEOPARD and Noonan syndrome on the PTPN11 gene. Am J Hum Genet 71:389–394

    Article  PubMed  CAS  Google Scholar 

  • Dumitrescu CE, Collins MT (2008) McCune-Albright syndrome. Orphanet J Rare Dis 3:12.

    Article  PubMed  Google Scholar 

  • Elefteriou F, Kolanczyk M, Schindeler A et al (2009) Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A 149A(10):2327–2338.

    Article  PubMed  CAS  Google Scholar 

  • Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314.

    Article  PubMed  CAS  Google Scholar 

  • Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans GH, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88.

    Article  PubMed  CAS  Google Scholar 

  • Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138–143

    Article  PubMed  CAS  Google Scholar 

  • Hyman SL, Arthur Shores E, North KN (2006) Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 48:973–977.

    Article  PubMed  Google Scholar 

  • Juhn E, Khachemoune A (2010) Gardner syndrome: skin manifestations, differential diagnosis and management. Am J Clin Dermatol 11:117–122.

    Article  PubMed  Google Scholar 

  • Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63–66

    Article  PubMed  CAS  Google Scholar 

  • Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198.

    Article  PubMed  CAS  Google Scholar 

  • Lodish MB, Stratakis CA (2011) The differential diagnosis of familial lentiginosis syndromes. Fam Cancer 10:481–490.

    Article  PubMed  Google Scholar 

  • Messiaen L, Riccardi V, Peltonen J, Maertens O, Callens T, Karvonen SL, Leisti E-L, Koivunen J, Vanderbroucke I, Stephens K, Pöyhönen M (2003) Independent NF1 mutations in two large families with spinal neurofibromatosis. J Med Genet 40:122–126.

    Article  PubMed  CAS  Google Scholar 

  • Messiaen L, Vogt J, Bengesser K, Fu C, Mikhail F, Serra E, Garcia-Linares C, Cooper DN, Lazaro C, Kehrer-Sawatzki H (2011) Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat 32:213–219

    Article  PubMed  CAS  Google Scholar 

  • Nguyen R, Kluwe L, Fuensterer C, Kentsch M, Friedrich RE, Mautner VF (2011) Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr 159:652–655.

    Article  PubMed  Google Scholar 

  • Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E (2009) Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer 53:1231–1237.

    Article  PubMed  Google Scholar 

  • Nowak CB (2007) The phakomatoses: dermatologic clues to neurologic anomalies. Semin Pediatr Neurol 14:140–149.

    Article  PubMed  Google Scholar 

  • Pasmant E, Sabbagh A, Spurlock G et al (2010) NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31:E1506–E1518.

    Article  PubMed  CAS  Google Scholar 

  • Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1988) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760–771

    PubMed  CAS  Google Scholar 

  • Poyhonen M (2000) A clinical assessment of neurofibromatoses in Northern Finland. J Med Genet 37:e43.

    Article  PubMed  CAS  Google Scholar 

  • Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA (2010) Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia. Pediatr Blood Cancer 54:173–175.

    Article  PubMed  Google Scholar 

  • Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433–1443

    Article  PubMed  CAS  Google Scholar 

  • Shah KN (2010) The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin North Am 57:1131–1153.

    Article  PubMed  Google Scholar 

  • Stevenson DA, Birch PH, Friedman JM et al (1999) Descriptive analysis of tibial pseudoarthrosis in patients with neurofibromatosis 1. Am J Med Genet 84:413–419

    Article  PubMed  CAS  Google Scholar 

  • Stumpf DA, Alksne JF, Annegers JF et al (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578

    Article  Google Scholar 

  • Szudek J, Birch P, Friedman JM et al (2000) Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 37:933–938

    Article  PubMed  CAS  Google Scholar 

  • Tsang E, Birch P, Friedman JM (2012) Valuing gene testing in children with possible neurofibromatosis 1. Clin Genet 82:591–593

    Google Scholar 

  • Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L (2007) An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 80:140–151

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Professor Juha Peltonen for valuable comments to the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sirkku Peltonen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Peltonen, S., Pöyhönen, M. (2012). Clinical Diagnosis and Atypical Forms of NF1. In: Upadhyaya, M., Cooper, D. (eds) Neurofibromatosis Type 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32864-0_2

Download citation

Publish with us

Policies and ethics